Peroxisome Proliferator-Activated Receptor α/γ Dual Agonists for the Treatment of Type 2 Diabetes

ADVERTISEMENT RETURN TO ISSUEPREVPerspectiveNEXTPeroxisome Proliferator-Activated Receptor α/γ Dual Agonists for the Treatment of Type 2 DiabetesBrad R. HenkeView Author Information Metabolic and Viral Diseases Drug Discovery Research, Five Moore Drive, GlaxoSmithKline, Research Triangle Park, North Carolina 27709 Cite this: J. Med. Chem. 2004, 47, 17, 4118–4127Publication Date (Web):July 20, 2004Publication History Received24 December 2003Published online20 July 2004Published inissue 1 August 2004https://pubs.acs.org/doi/10.1021/jm030631ehttps://doi.org/10.1021/jm030631ereview-articleACS PublicationsCopyright © 2004 American Chemical SocietyRequest reuse permissionsArticle Views1373Altmetric-Citations126LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Agonists,Lipids,Peptides and proteins,Receptors,Rodent models Get e-Alerts